Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -67.01x is 94% below its 4-year average of -34.45x, near the low end of its 4-year range (-76.52x–-5.57x).
9.65% below its 12-month average of -61.11x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -66.40x.
INTEREST COVERAGE RATIO
-67.01x
INTEREST COVERAGE RATIO AVG TTM
-61.11x
INTEREST COVERAGE RATIO AVG 3Y
-39.53x
INTEREST COVERAGE RATIO AVG 5Y
-34.45x
INTEREST COVERAGE RATIO AVG 10Y
-34.45x
INTEREST COVERAGE RATIO AVG 15Y
-33.13x
INTEREST COVERAGE RATIO AVG 20Y
-33.13x
CURRENT VS TTM AVG
-9.65%
CURRENT VS 3Y AVG
-69.52%
CURRENT VS 5Y AVG
-94.50%
CURRENT VS 10Y AVG
-94.50%
CURRENT VS 15Y AVG
-102.29%
CURRENT VS 20Y AVG
-102.29%
SECTOR MEDIAN · HEALTHCARE
-5.54x
median of 430 covered companies
CURRENT VS SECTOR MEDIAN
-1109.57%
vs the sector median at left
Achieve Life Sciences, Inc.
Market Cap
$740.17M
Interest Coverage Ratio
-67.01x
TTM Avg
-61.11x
3Y Avg
-39.53x
5Y Avg
-34.45x
Market Cap
$747.44M
Interest Coverage Ratio
-696.50x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$725.41M
Interest Coverage Ratio
N/A
TTM Avg
578.36x
3Y Avg
578.36x
5Y Avg
578.36x
Market Cap
$752.87M
Interest Coverage Ratio
-22.78x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$723.20M
Interest Coverage Ratio
-85.20x
TTM Avg
23.14x
3Y Avg
23.14x
5Y Avg
23.14x
Market Cap
$722.58M
Interest Coverage Ratio
2.27x
TTM Avg
2.29x
3Y Avg
1.77x
5Y Avg
1.65x
Market Cap
$715.38M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$770.55M
Interest Coverage Ratio
1.73x
TTM Avg
1.55x
3Y Avg
1.27x
5Y Avg
1.31x
Market Cap
$770.72M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Achieve Life Sciences, Inc. (ACHV) | $740.17M | -67.01x | -61.11x | -39.53x | -34.45x |
| Faeth Therapeutics, Inc. (FTH)vs › | $747.44M | -696.50x | N/A | N/A | N/A |
| Avalo Therapeutics, Inc. (AVTX)vs › | $725.41M | N/A | 578.36x | 578.36x | 578.36x |
| Candel Therapeutics, Inc. (CADL)vs › | $752.87M | -22.78x | N/A | N/A | N/A |
| Cytek Biosciences, Inc. (CTKB)vs › | $723.20M | -85.20x | 23.14x | 23.14x | 23.14x |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $722.58M | 2.27x | 2.29x | 1.77x | 1.65x |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $715.38M | N/A | N/A | N/A | N/A |
| Mesa Laboratories, Inc. (MLAB)vs › | $770.55M | 1.73x | 1.55x | 1.27x | 1.31x |
| Design Therapeutics, Inc. (DSGN)vs › | $770.72M | N/A | N/A | N/A | N/A |
| Attovia Therapeutics, Inc. (ATTO)vs › | $780.99M | N/A | N/A | N/A | N/A |
Interest Coverage
-67.0x
Debt/Equity
N/A
Current Ratio
0.95
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -66.40x |
| 2026-03-31 | -38.19x |
| 2025-12-31 | -58.69x |
| 2025-09-30 | -76.52x |
| 2025-06-30 | -65.77x |
| 2025-03-31 | -69.70x |
| 2024-12-31 | -61.88x |
| 2024-09-30 | -34.06x |
| 2024-06-30 | -10.49x |
| 2024-03-31 | -7.36x |
| 2023-12-31 | -5.57x |
| 2023-09-30 | -8.41x |
| 2023-06-30 | -10.83x |
| 2023-03-31 | -14.97x |
| 2022-12-31 | -19.86x |
| 2022-09-30 | -26.28x |
| 2022-06-30 | -24.93x |
| 2022-03-31 | -20.24x |
| 2014-09-30 | -9.24x |
| 2007-06-30 | -52427.81x |
| 2006-12-31 | -15784.31x |
| 2006-09-30 | -10763.44x |
| 2006-06-30 | -6749.80x |
| 2006-03-31 | -5825.21x |
| 2005-12-31 | -3215.20x |
| 2005-06-30 | -2425.50x |
| 2005-03-31 | -1853.86x |
| 2004-12-31 | -1526.81x |
| 2004-06-30 | -519.52x |
| 2004-03-31 | -422.07x |
| 2003-12-31 | -301.79x |
| 2003-09-30 | -305.63x |
| 2002-12-31 | -204.43x |
| 2002-09-30 | -302.78x |
